CN Patent

CN113197874B — 一种磷酸特地唑胺口服固体制剂

Assigned to Beijing Fuyuan Pharmaceutical Co ltd · Expires 2023-05-26 · 3y expired

What this patent protects

本发明涉及一种磷酸特地唑胺口服固体制剂，该口服固体制剂具体包括磷酸特地唑胺、麦芽糊精、磷酸氢钙和崩解剂，其中，磷酸特地唑胺的粒径d0.9不大于30um。本发明制得的磷酸特地唑胺口服固体制剂具有较好的溶出度，克服了磷酸特地唑胺流动性差的问题，保证制剂在制备过程中的工艺顺畅性。

USPTO Abstract

本发明涉及一种磷酸特地唑胺口服固体制剂，该口服固体制剂具体包括磷酸特地唑胺、麦芽糊精、磷酸氢钙和崩解剂，其中，磷酸特地唑胺的粒径d0.9不大于30um。本发明制得的磷酸特地唑胺口服固体制剂具有较好的溶出度，克服了磷酸特地唑胺流动性差的问题，保证制剂在制备过程中的工艺顺畅性。

Drugs covered by this patent

Patent Metadata

Patent number
CN113197874B
Jurisdiction
CN
Classification
—
Expires
2023-05-26
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Fuyuan Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.